journal article·2024-12-11

Multifunctional “Add-On” Module Enabled NIR-II Imaging-Guided Synergistic Photothermal and Chemotherapy of Drug-Resistant Lung Cancer

Yu Li, Qiang Zhu, Pei He, Tingjuan Wu, Zhen Ouyang, Lijun Zhu, Fang Wang, Xin Zhou, Zhong-Xing Jiang, Shizhen Chen

ACS Applied Materials & Interfaces· Volume 16· Issue 49
Publisher page

Abstract

Imaging-guided chemo-photothermal combination therapy (chemo-PTT) is recognized for its synergistic therapeutic effects, reduced side effects, and minimal drug resistance, while the development of such theranostics has been hampered by poor imaging and therapy performance and tedious formulation. Herein, we introduce an all-in-one “add-on” module ( BBT-C6 ) for the convenient construction of doxorubicin (DOX)-loaded nanoparticles (DOX@BBT) and efficient second near-infrared (NIR-II) fluorescence imaging (FLI)-guided synergistic chemo-PTT of drug-resistant lung cancer. The delicate Janus amphiphilic structure of BBT-C6 enables multifunctionality, including NIR-II FLI, aggregation-induced emission (AIE) characteristics, moderate photothermal conversion efficiency (PCE), excellent photostability, and polyethylene glycolation (PEGylation), which could improve the NIR-II FLI and PTT performance, relieve the complexity in theranostics, and enable high reproducibility of the multifunctional theranostics. Confocal microscopy revealed that BBT@DOX efficiently delivers DOX into cells, resulting in an increased accumulation of DOX that exceeds the efflux capacity of DOX-resistant cells. Both in vitro and in vivo studies demonstrate that BBT-C6 enhances the effectiveness of BBT@DOX, achieving highly effective photothermal-chemo synergistic therapy against DOX-resistant lung cancer. Beyond developing a versatile “add-on” module for conveniently constructing multifunctional nanosystems, this study provides new insights into the design of advanced theranostics for precise biomedical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, Wuhan 430071, China

University of Chinese Academy of Sciences, Beijing 100049, China

School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China

Funding

China Postdoctoral Science Foundation · Youth Innovation Promotion Association of the Chinese Academy of Sciences · Natural Science Foundation of Hubei Province · National Natural Science Foundation of China · Chinese Academy of Sciences · Hubei Province

References (58)

Show source-provided references
1. 10.1039/C8CS00618K10.1039/C8CS00618K ↗
2. 10.1016/j.pmatsci.2018.07.00510.1016/j.pmatsci.2018.07.005 ↗
3. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
4. 10.1039/C6CS00908E10.1039/C6CS00908E ↗
5. 10.1016/j.addr.2022.11448310.1016/j.addr.2022.114483 ↗
6. 10.1016/j.jconrel.2023.08.05610.1016/j.jconrel.2023.08.056 ↗
7. 10.1021/acsami.4c0491310.1021/acsami.4c04913 ↗
8. 10.1002/smll.20220203510.1002/smll.202202035 ↗
9. 10.1038/s41566-024-01391-510.1038/s41566-024-01391-5 ↗
10. 10.1021/jacs.0c0702210.1021/jacs.0c07022 ↗
11. 10.1016/j.ccr.2022.21456410.1016/j.ccr.2022.214564 ↗
12. 10.1002/anie.20211472210.1002/anie.202114722 ↗
13. 10.1021/acsami.1c0201910.1021/acsami.1c02019 ↗
14. 10.1002/smtd.20210135910.1002/smtd.202101359 ↗
15. 10.1002/adma.20220013910.1002/adma.202200139 ↗
16. 10.1021/acsami.9b1506410.1021/acsami.9b15064 ↗
17. 10.1002/anie.20200589910.1002/anie.202005899 ↗
18. 10.1021/acsami.9b1396610.1021/acsami.9b13966 ↗
19. 10.1021/jacs.6b1138210.1021/jacs.6b11382 ↗
20. 10.1021/acsami.1c0570510.1021/acsami.1c05705 ↗
21. 10.1038/s41467-018-03473-910.1038/s41467-018-03473-9 ↗
22. 10.1039/D0CS00664E10.1039/D0CS00664E ↗
23. 10.7150/thno.5648210.7150/thno.56482 ↗
24. 10.1002/adma.20180593610.1002/adma.201805936 ↗
25. 10.1038/s41467-019-12313-310.1038/s41467-019-12313-3 ↗
26. 10.1002/adma.20210059910.1002/adma.202100599 ↗
27. 10.1021/acsami.1c1003610.1021/acsami.1c10036 ↗
28. 10.1002/adhm.20220115810.1002/adhm.202201158 ↗
29. 10.1016/j.mtbio.2021.10019710.1016/j.mtbio.2021.100197 ↗
30. 10.1002/adma.20230661610.1002/adma.202306616 ↗
31. 10.1021/acsami.1c0226010.1021/acsami.1c02260 ↗
32. 10.1002/adhm.20190133110.1002/adhm.201901331 ↗
33. 10.1021/acsami.2c1916110.1021/acsami.2c19161 ↗
34. 10.1016/j.addr.2022.11453610.1016/j.addr.2022.114536 ↗
35. 10.1002/adhm.20230094110.1002/adhm.202300941 ↗
36. 10.1021/acs.chemrev.5b0040010.1021/acs.chemrev.5b00400 ↗
37. 10.1021/acscatal.7b0384110.1021/acscatal.7b03841 ↗
38. 10.1039/D0CY02059A10.1039/D0CY02059A ↗
39. 10.1016/j.jct.2012.05.02110.1016/j.jct.2012.05.021 ↗
40. 10.1016/j.jcis.2005.07.00610.1016/j.jcis.2005.07.006 ↗
41. 10.1021/acs.chemrev.5b0029210.1021/acs.chemrev.5b00292 ↗
42. 10.1021/acsnano.2c0946410.1021/acsnano.2c09464 ↗
43. 10.1016/j.nantod.2022.10173810.1016/j.nantod.2022.101738 ↗
44. 10.1039/D3TB02068A10.1039/D3TB02068A ↗
45. 10.1021/acs.accounts.2c0041910.1021/acs.accounts.2c00419 ↗
46. 10.1021/jacs.2c0744310.1021/jacs.2c07443 ↗
47. 10.1021/acsnano.3c1231610.1021/acsnano.3c12316 ↗
48. 10.1002/adhm.20240084610.1002/adhm.202400846 ↗
49. 10.1016/j.colsurfb.2023.11351610.1016/j.colsurfb.2023.113516 ↗
50. 10.1021/jacs.8b1388910.1021/jacs.8b13889 ↗
51. 10.1002/adma.20200114610.1002/adma.202001146 ↗
52. 10.1016/j.nantod.2016.04.00810.1016/j.nantod.2016.04.008 ↗
53. 10.3109/07388551.2015.101595710.3109/07388551.2015.1015957 ↗
54. 10.1038/s41586-019-1730-110.1038/s41586-019-1730-1 ↗
55. 10.1126/science.aar738910.1126/science.aar7389 ↗
56. 10.1039/C6CS00636A10.1039/C6CS00636A ↗
57. 10.1021/acs.langmuir.3c0043910.1021/acs.langmuir.3c00439 ↗
58. 10.1038/s41419-021-04320-410.1038/s41419-021-04320-4 ↗